TY  - GEN
AU  - Liang,Yingjian
AU  - Zheng,Tongsen
AU  - Song,Ruipeng
AU  - Wang,Jiabei
AU  - Yin,Dalong
AU  - Wang,Luoluo
AU  - Liu,Haitao
AU  - Tian,Lantian
AU  - Fang,Xiang
AU  - Meng,Xianzhi
AU  - Jiang,Hongchi
AU  - Liu,Jiaren
AU  - Liu,Lianxin
TI  - Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma
SN  - 1527-3350
PY  - 2013///0705
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Benzylidene Compounds
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - Cell Survival
KW  - Drug Resistance, Neoplasm
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Hypoxia
KW  - physiopathology
KW  - Hypoxia-Inducible Factor 1, alpha Subunit
KW  - antagonists & inhibitors
KW  - Liver Neoplasms
KW  - Male
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - NF-kappa B
KW  - metabolism
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Piperidones
KW  - Sorafenib
KW  - Treatment Outcome
KW  - Von Hippel-Lindau Tumor Suppressor Protein
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hep.26224
ER  -